Home・Akcijų sąrašas・Codexis Inc

Codexis Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

1.47 -25.38

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

1.46

Max

1.55

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-18M -8.7M
Pardavimai	-24M 15M
Pelnas, tenkantis vienai akcijai	-0.1
Pelno marža	-57.083
Darbuotojai	146
EBITDA	-23M -6.4M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+395.27% upside

Dividendai
By Acuity
Kitas uždarbis	2026-08-12

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-27M 201M
Ankstesnė atidarymo kaina	26.85
Ankstesnė uždarymo kaina	1.47

Naujienos nuotaikos

By Acuity

30%

70%

76 / 340 reitingas Healthcare

Codexis Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-07-24 19:01; UTC

News

Codexis Inc shares are lower following a public offering of 16.67 million shares at $1.50 each, below Thursday's close of $1.99.

2026-07-23 23:51; UTC

News

Codexis Inc announced a public offering of common stock, contributing to a notable decline in shares during after-market trading.

2026-07-22 20:01; UTC

Codexis Inc shares are lower during Wednesday's session, continuing a trend of declines since Tuesday's close. The stock remains below its 20-day moving average.

Akcijų palyginimas

Kainos pokytis

Codexis Inc Prognozė

Kainos tikslas

By TipRanks

395.27% į viršų

12 mėnesių prognozė

Vidutinis 7.33 USD 395.27%

Aukščiausias 11 USD

Žemiausias 2 USD

Remiantis 4 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Codexis Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

4 ratings

Pirkti

Laikyti

Parduoti

Remiantis 4 analitikų, pateikusių Codexis Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Rinkos nuotaikos

By Acuity

76 / 340 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.